MA12.08 Chemotherapy plus EGFR TKIs or Bevacizumab versus Chemotherapy Alone in SCLC-Transformed EGFR-Mutant Lung Adenocarcinoma

Category Primary study
JournalJournal of Thoracic Oncology
Year 2021
This article has no abstract
Epistemonikos ID: d48a6a49ca93c374d2dc048bc2c2535284901de0
First added on: Feb 12, 2025